Abstract
Stem cells play a pivotal role in the developmental stages of an organism and in adulthood as well. Therefore, it is not surprising that stem cells constitute a focus of extensive research. Indeed, several decades of stem cell research have tremendously increased our knowledge on the mechanistic understandings of stem cell biology. Interestingly, revealing the fundamental principles of stem cell biology has also fostered its application for therapeutic purposes. Many of the attributes that the stem cells possess, some of which are unique, allow multifaceted exploitation of stem cells in the treatment of various diseases. Cancer, the leading cause of mortality worldwide, is one of the disease groups that has been benefited by the potentials of therapeutic applications of the stem cells. While the modi operandi of how stem cells contribute to cancer treatment are many-sided, two major principles can be conceived. One mode involves harnessing the regenerative power of the stem cells to promote the generation of blood-forming cells in cancer patients after cytotoxic regimens. A totally different kind of utility of stem cells has been exercised in another mode where the stem cells can potentially deliver a plethora of anti-cancer therapeutics in a tumor-specific manner. While both these approaches can improve the treatment of cancer patients, there exist several issues that warrant further research. This review summarizes the basic principles of the utility of the stem cells in cancer treatment along with the current trends and pinpoints the major obstacles to focus on in the future for further improvement.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ALL:
-
Acute lymphoblastic leukemia
- AML:
-
Acute myeloid leukemia
- bCD:
-
Bacterial cytosine deaminase
- BM:
-
Bone marrow
- CAR:
-
Coxsackievirus–adenovirus receptor
- CNS:
-
Central nervous system
- EGF:
-
Epidermal growth factor
- EPGT:
-
Enzyme/prodrug gene therapy
- ESCs:
-
Embryonic stem cells
- EVs:
-
Extracellular vesicles
- GVHD:
-
Graft-versus-host disease
- HGF:
-
Hepatocyte growth factor
- HSCs:
-
Hematopoietic stem cells
- HSV-1:
-
Herpes simplex virus type 1
- HSV-TK:
-
Herpes simplex virus thymidine kinase gene
- iPSCs:
-
Induced pluripotent stem cells
- MSCs:
-
Mesenchymal stem cells
- MVBs:
-
Multi-vesicular bodies
- NSCs:
-
Neural stem cells
- OVs :
-
Oncolytic viruses
- PTX:
-
Paclitaxel
- SSCs:
-
Somatic stem cells
- VEGF:
-
Vascular endothelial growth factor
References
Aboody KS et al (2000) Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A 97(23):12846–12851
Aboody KS et al (2008) Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 15(10):739–752
Adams GB (2006) Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439(7076):599–603
Adamiak M et al (2015) Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow. Oncotarget 6(22):18819–18828
Ahmed AU et al (2011) Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. Mol Ther 19(9):1714–1726
Altaner C et al (2014) Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario. Int J Cancer 134(6):1458–1465
Alvarez-Erviti L et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341–345
Antimisiaris SG et al (2018) Exosomes and exosome-inspired vesicles for targeted drug delivery. Pharmaceutics 10(4):218
Appelbaum FR (2007) Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission. Best Pract Res Clin Haematol 20(1):67–75
Araki R et al (2013) Negligible immunogenicity of terminally differentiated cells derived from or embryonic stem cells. Nature 494(7435):100–104
Balyasnikova IV et al (2014) Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors. Mol Ther 22(1):140–148
Barish ME et al (2017) Human neural stem cell biodistribution and predicted tumor coverage by a diffusible therapeutic in a mouse glioma model. Stem Cells Transl Med 6(6):1522–1532
Batlle E et al (1963) Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197:452–454
Becker AJ et al (1963) Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197:452–454
Benedetti S et al (2000) Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 6(4):447–450
Beveridge TJ (1999) Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol 181(16):4725–4733
Boockvar JA et al (2003) Constitutive EGFR signaling confers a motile phenotype to neural stem cells. Mol Cell Neurosci 24(4):1116–1130
Brenner S et al (2004) CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells. Stem Cells 22(7):1128–1133
Brossa A et al (2020) Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo. Int J Cancer 147(6):1694–1706
Bruno S et al (2013) Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev 22(5):758–771
Brustle O et al (1997) In vitro-generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci U S A 94(26):14809–14814
Casper J et al (2010) Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning. J Clin Oncol 28(20):3344–3351
Chabannon C et al (2018) Hematopoietic stem cell transplantation in its 60s: a platform for cellular therapies. Sci Transl Med 10(436):eaap9630
Chagastelles PC et al (2011) Biology of stem cells: an overview. Kidney Int Suppl 1(3):63–67
Chang DY et al (2010) The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase. Int J Cancer 127(8):1975–1983
Chargaff E et al (1946) The biological significance of the thromboplastic protein of blood. J Biol Chem 166(1):189–197
Chatterjee SN et al (1967) Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae. J Gen Microbiol 49(1):1–11
Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354(17):1813–1826
Coukos G et al (1999) Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer. Clin Cancer Res 5(6):1523–1537
Crescitelli R et al (2013) Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles 2:20677
de Almeida PE et al (2014) Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nat Commun 5:3903
Dohner H et al (2015) Acute Myeloid Leukemia. N Engl J Med 373(12):1136–1152
Du W et al (2017) Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas. Proc Natl Acad Sci U S A 114(30):E6157–E6165
Edwards RG (2001) IVF and the history of stem cells. Nature 413(6854):349–351
Ellis TN et al (2010) Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 74(1):81–94
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495–516
Erlandsson A et al (2004) Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. Exp Cell Res 301(2):201–210
Evans MJ et al (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819):154–156
Fonsato V et al (2012) Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells 30(9):1985–1998
Friedenstein AJ (1976) Precursor cells of mechanocytes. Int Rev Cytol 47:327–359
Friedenstein AJ et al (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3(4):393–403
Fuhrmann G et al (2015) Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release 205:35–44
Goldman JM et al (1986) Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 314(4):202–207
Gomes JPA et al (2017) Deepening a simple question: can MSCs be used to treat cancer? Anticancer Res 37(9):4747–4758
Gyorgy B et al (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68(16):2667–2688
Hakkarainen T et al (2007) Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors. Hum Gene Ther 18(7):627–641
Hammad M et al (2020) Neural stem cells improve the delivery of oncolytic chimeric Orthopoxvirus in a metastatic ovarian cancer model. Mol Ther Oncolytics 18:326–334
Hammer K et al (2015) Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells. Int J Cancer 137(4):978–990
Hao SC et al (2019) hUC-MSCs secreted exosomes inhibit the glioma cell progression through PTENP1/miR-10a-5p/PTEN pathway. Eur Rev Med Pharmacol Sci 23(22):10013–10023
Harrington K et al (2019) Optimizing oncolytic virotherapy in cancer treatment. Nat Rev Drug Discov 18(9):689–706
He Z et al (2020) Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression. J Exp Clin Cancer Res 39(1):140
Henig I et al (2014) Hematopoietic stem cell transplantation-50 years of evolution and future perspectives. Rambam Maimonides Med J 5(4):e0028
Herrlinger U et al (2000) Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther 1(4):347–357
Hossain JA et al (2019a) Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma. Neuro-Oncology 21(7):890–900
Hossain JA et al (2019b) Cancer suicide gene therapy with TK.007. Methods Mol Biol 1895:11–26
Hossain JA et al (2020a) Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects. Neurooncol Adv 2(1):vdaa013
Hossain JA et al (2020b) Letter regarding “Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas”. Neuro-Oncology 22(12):1882–1883
Imitola J et al (2004) Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101(52):18117–18122
Joo KM et al (2009) Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. Mol Ther 17(3):570–575
Josiah DT et al (2010) Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma. Mol Ther 18(2):377–385
Kahn J et al (2004) Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 103(8):2942–2949
Kalimuthu S et al (2018) A new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapy. Front Pharmacol 9:1116
Katakowski M et al (2013) Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett 335(1):201–204
Kauer TM et al (2011) Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Nat Neurosci 15(2):197–204
Kazimirsky G et al (2016) Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL. Stem Cell Res Ther 7(1):149
Keirstead HS et al (2005) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25(19):4694–4705
Kendall SE et al (2008) Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling. Stem Cells 26(6):1575–1586
Kerr JF et al (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26(4):239–257
Kersey JH et al (1987) Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 317(8):461–467
Kim SK et al (2006) Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 12(18):5550–5556
Kim CK et al (2013) N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy. Mol Ther 21(11):2063–2073
Kim J et al (2015) Stem cell-based cell carrier for targeted oncolytic Virotherapy: translational opportunity and open questions. Viruses 7(12):6200–6217
Lapidot T et al (2005) How do stem cells find their way home? Blood 106(6):1901–1910
Le Blanc K, Ringden O (2007) Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262(5):509–525
Lee RH (2011) Therapeutic factors secreted by mesenchymal stromal cells and tissue repair. J Cell Biochem 112(11):3073–3078
Lee JK et al (2013) Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One 8(12):e84256
Lee JY et al (2014) Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures. J Neuro-Oncol 116(1):49–57
Li YH et al (2015) Intranasal delivery of stem cells as therapy for central nervous system disease. Exp Mol Pathol 98(2):145–151
Lin HT et al (2013) Stem cell therapy: an exercise in patience and prudence. Philos Trans R Soc Lond Ser B Biol Sci 368(1609):20110334
Lopatina T et al (2019) Extracellular vesicles from human liver stem cells inhibit tumor angiogenesis. Int J Cancer 144(2):322–333
Lotvall J et al (2014) Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 3:26913
Lunavat TR et al (2015) Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells–evidence of unique microRNA cargos. RNA Biol 12(8):810–823
Ma T et al (2018) MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction. Stem Cells Int 2018:3290372
Maeda H et al (2018) Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs. Clin Transl Med 7(1):11
Malekshah OM et al (2016) Enzyme/prodrug systems for cancer gene therapy. Curr Pharmacol Rep 2(6):299–308
Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78(12):7634–7638
Mason C et al (2008) A brief definition of regenerative medicine. Regen Med 3(1):1–5
Mateescu B et al (2017) Obstacles and opportunities in the functional analysis of extracellular vesicle RNA – an ISEV position paper. J Extracell Vesicles 6(1):1286095
Matuskova M et al (2010) HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Lett 290(1):58–67
Mead B et al (2017) Bone marrow-derived mesenchymal stem cells-derived exosomes promote survival of retinal ganglion cells through miRNA-dependent mechanisms. Stem Cells Transl Med 6(4):1273–1285
Melzer C et al (2019) Taxol-loaded MSC-derived exosomes provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells. Cancers (Basel) 11(6):798
Menard C et al (2005) Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366(9490):1005–1012
Mendez-Ferrer S et al (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466(7308):829–834
Metz MZ et al (2013) Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use. Stem Cells Transl Med 2(12):983–992
Micheau O et al (2013) Death receptors as targets in cancer. Br J Pharmacol 169(8):1723–1744
Miletic H et al (2007) Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther 15(7):1373–1381
Minguell JJ et al (2001) Mesenchymal stem cells. Exp Biol Med (Maywood) 226(6):507–520
Mooney R et al (2017) Cell-mediated enzyme prodrug cancer therapies. Adv Drug Deliv Rev 118:35–51
Mooney R et al (2018a) Concise review: neural stem cell-mediated targeted cancer therapies. Stem Cells Transl Med 7(10):740–747
Mooney R et al (2018b) Bcl-2 overexpression improves survival and efficacy of neural stem cell-mediated enzyme prodrug therapy. Stem Cells Int 2018:7047496
Moore C et al (2017) The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy. Int J Cancer 141(3):428–436
Munoz JL et al (2013) Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol Ther Nucleic Acids 2:e126
Murphy MB et al (2013) Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 45:e54
Naseri Z et al (2018) Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo. Int J Nanomedicine 13:7727–7747
Nishikawa S et al (2008) The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 9(9):725–729
Niederwieser D et al (2016) Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplant 51(6):778–785
Nombela-Arrieta C et al (2011) The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol 12(2):126–131
Okajima F (2013) Regulation of inflammation by extracellular acidification and proton-sensing GPCRs. Cell Signal 25(11):2263–2271
Pascucci L et al (2014) Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release 192:262–270
Pastorakova A et al (2020) Suicide gene therapy mediated with exosomes produced by mesenchymal stem/stromal cells stably transduced with HSV thymidine kinase. Cancers (Basel) 12(5):1096
Portnow J et al (2017) Neural stem cell-based anticancer gene therapy: a first-in-human study in recurrent high-grade glioma patients. Clin Cancer Res 23(12):2951–2960
Raab S et al (2011) A Comparative View on Human Somatic Cell Sources for iPSC Generation. Stem Cells Int. 2014; 2014:768391
Rossi L et al (2007) The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood 109(2):533–542
Sacchetti B et al (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131(2):324–336
Sansone P et al (2017) Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proc Natl Acad Sci U S A 114(43):E9066–E9075
Schmidt NO et al (2005) Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 7(6):623–629
Sharma A (2018) Role of stem cell derived exosomes in tumor biology. Int J Cancer 142(6):1086–1092
Shimato S et al (2007) Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Gene Ther 14(15):1132–1142
Short MP et al (1990) Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res 27(3):427–439
Siegel RL et al (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30
Siminovitch L et al (1963) The distribution of colony-forming cells among spleen colonies. J Cell Comp Physiol 62:327–336
Singh AK et al (2016) Fatal GvHD induced by PD-1 inhibitor pembrolizumab in a patient with Hodgkin’s lymphoma. Bone Marrow Transplant 51(9):1268–1270
Skog J et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470–1476
Sonabend AM et al (2008) Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells 26(3):831–841
Sullivan CB et al (2014) TNFalpha and IL-1beta influence the differentiation and migration of murine MSCs independently of the NF-kappaB pathway. Stem Cell Res Ther 5(4):104
Sutaria DS et al (2017) Achieving the promise of therapeutic extracellular vesicles: the devil is in details of therapeutic loading. Pharm Res 34(5):1053–1066
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Takahashi K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872
Thery C et al (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9(8):581–593
Thery C et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750
Thomas ED et al (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257(11):491–496
Thomas ED et al (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow. Blood 49(4):511–533
Thomson JA et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Toh WS et al (2018) MSC exosome works through a protein-based mechanism of action. Biochem Soc Trans 46(4):843–853
Uchibori R et al (2013) NF-kappaB activity regulates mesenchymal stem cell accumulation at tumor sites. Cancer Res 73(1):364–372
Vakhshiteh F et al (2019) Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy. Int J Nanomedicine 14:2847–2859
Valadi H et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659
Vallabhaneni KC et al (2015) Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget 6(7):4953–4967
van Niel G et al (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19(4):213–228
Vasconcelos MH et al (2019) Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance. Drug Resist Updat 47:100647
Walters MC et al (1996) Bone marrow transplantation for sickle cell disease. N Engl J Med 335(6):369–376
Wang C et al (2012) Neural stem cell-based dual suicide gene delivery for metastatic brain tumors. Cancer Gene Ther 19(11):796–801
Weissman IL (2000) Stem cells: units of development, units of regeneration, and units in evolution. Cell 100(1):157–168
Widera D et al (2004) MCP-1 induces migration of adult neural stem cells. Eur J Cell Biol 83(8):381–387
Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13(3):269–288
Yanez-Mo M et al (2015) Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 4:27066
Yokoi A et al (2019) Mechanisms of nuclear content loading to exosomes. Sci Adv 5(11):eaax8849
Yu JMA et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917–1920
Yuan Z et al (2017) TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy. J Extracell Vesicles 6(1):1265291
Zhang TY et al (2014) Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection. Nanomedicine 10(1):257–267
Zhao R et al (2008) From fibroblasts to iPS cells: induced pluripotency by defined factors. J Cell Biochem 105(4):949–955
Zhu W et al (2012) Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett 315(1):28–37
Zuk PA et al (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7(2):211–228
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Das, M.K., Lunavat, T.R., Miletic, H., Hossain, J.A. (2021). The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 12. Advances in Experimental Medicine and Biology(), vol 1326. Springer, Cham. https://doi.org/10.1007/5584_2021_619
Download citation
DOI: https://doi.org/10.1007/5584_2021_619
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71932-6
Online ISBN: 978-3-030-71933-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)